Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group

Volume 327:1906-1911		December 31, 1992		Number 27

Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group

LB Seeff, Z Buskell-Bales, EC Wright, SJ Durako, HJ Alter, FL Iber, FB Hollinger, G Gitnick, RG Knodell, RP Perrillo, and et al.

Abstract

Add to Personal Archive

Add to Citation Manager

E-mail When Cited

PubMed Citation

Veterans Affairs Medical Center, Washington, DC 20422.

This article has been cited by other articles:

Zinkin, N. T., Grall, F., Bhaskar, K., Otu, H. H., Spentzos, D., Kalmowitz, B., Wells, M., Guerrero, M., Asara, J. M., Libermann, T. A., Afdhal, N. H. (2008). Serum Proteomics and Biomarkers in Hepatocellular Carcinoma and Chronic Liver Disease. Clin. Cancer Res. 14: 470-477 [Abstract] [Full Text]
McNelis, K. (2006). Management of Hepatitis C Infection in the HIV-Infected Patient. Journal of Pharmacy Practice 19: 37-52 [Abstract]
Shiratori, Y., Ito, Y., Yokosuka, O., Imazeki, F., Nakata, R., Tanaka, N., Arakawa, Y., Hashimoto, E., Hirota, K., Yoshida, H., Ohashi, Y., Omata, M., for the Tokyo-Chiba Hepatitis Research Group*, (2005). Antiviral Therapy for Cirrhotic Hepatitis C: Association with Reduced Hepatocellular Carcinoma Development and Improved Survival. ANN INTERN MED 142: 105-114 [Abstract] [Full Text]
Ludwig, I. S., Lekkerkerker, A. N., Depla, E., Bosman, F., Musters, R. J. P., Depraetere, S., van Kooyk, Y., Geijtenbeek, T. B. H. (2004). Hepatitis C Virus Targets DC-SIGN and L-SIGN To Escape Lysosomal Degradation. J. Virol. 78: 8322-8332 [Abstract] [Full Text]
Peffault de Latour, R., Levy, V., Asselah, T., Marcellin, P., Scieux, C., Ades, L., Traineau, R., Devergie, A., Ribaud, P., Esperou, H., Gluckman, E., Valla, D., Socie, G. (2004). Long-term outcome of hepatitis C infection after bone marrow transplantation. Blood 103: 1618-1624 [Abstract] [Full Text]
Krahn, M., Wong, J. B., Heathcote, J., Scully, L., Seeff, L. (2004). Estimating the Prognosis of Hepatitis C Patients Infected by Transfusion in Canada between 1986 and 1990. Med Decis Making 24: 20-29 [Abstract]
Hui, C-K, Monto, A, Belaye, T, Lau, E, Wright, T L (2003). Outcomes of interferon {alpha} and ribavirin treatment for chronic hepatitis C in patients with normal serum aminotransaminases. Gut 52: 1644-1648 [Abstract] [Full Text]
Wright, M, Goldin, R, Fabre, A, Lloyd, J, Thomas, H, Trepo, C, Pradat, P, Thursz, M (2003). Measurement and determinants of the natural history of liver fibrosis in hepatitis C virus infection: a cross sectional and longitudinal study. Gut 52: 574-579 [Abstract] [Full Text]
Sulkowski, M. S., Thomas, D. L. (2003). Hepatitis C in the HIV-Infected Person. ANN INTERN MED 138: 197-207 [Abstract] [Full Text]
Kuehne, F. C., Bethe, U., Freedberg, K., Goldie, S. J. (2002). Treatment for Hepatitis C Virus in Human Immunodeficiency Virus-Infected Patients: Clinical Benefits and Cost-effectiveness. Arch Intern Med 162: 2545-2556 [Abstract] [Full Text]
Salomon, J. A., Weinstein, M. C., Hammitt, J. K., Goldie, S. J. (2002). Empirically Calibrated Model of Hepatitis C Virus Infection in the United States. Am J Epidemiol 156: 761-773 [Abstract] [Full Text]
Herrine, S. K. (2002). Approach to the Patient with Chronic Hepatitis C Virus Infection. ANN INTERN MED 136: 747-757 [Abstract] [Full Text]
Harris, H. E, Ramsay, M. E, Andrews, N., Eldridge, K. P (2002). Clinical course of hepatitis C virus during the first decade of infection: cohort study. BMJ 324: 450-450 [Abstract] [Full Text]
Stein, K, Rosenberg, W, Wong, J (2002). Cost effectiveness of combination therapy for hepatitis C: a decision analytic model. Gut 50: 253-258 [Abstract] [Full Text]
DAY, C P (2001). Heavy drinking greatly increases the risk of cirrhosis in patients with HCV hepatitis. Gut 49: 750-751 [Full Text]
Espinosa, M., Martin-Malo, A., de Lara, M. A. A., Aljama, P. (2001). Risk of death and liver cirrhosis in anti-HCV-positive long-term haemodialysis patients. Nephrol Dial Transplant 16: 1669-1674 [Abstract] [Full Text]
Kelley, V. A., Caliendo, A. M. (2001). Successful Testing Protocols in Virology. Clin. Chem. 47: 1559-1562 [Abstract] [Full Text]
Lauer, G. M., Walker, B. D. (2001). Hepatitis C Virus Infection. NEJM 345: 41-52 [Full Text]
Booth, J C L, O'Grady, J, Neuberger, J (2001). Clinical guidelines on the management of hepatitis C. Gut 49: I1-21 [Full Text]
Mohsen, A H, Group, T. H. S. (2001). The epidemiology of hepatitis C in a UK health regional population of 5.12 million. Gut 48: 707-713 [Abstract] [Full Text]
Simmonds, P. (2001). 2000 Fleming Lecture. The origin and evolution of hepatitis viruses in humans. J. Gen. Virol. 82: 693-712 [Abstract] [Full Text]
Jowett, S.L., Agarwal, K., Smith, B.C., Craig, W., Hewett, M., Bassendine, D.R., Gilvarry, E., Burt, A.D., Bassendine, M.F. (2001). Managing chronic hepatitis C acquired through intravenous drug use. QJM 94: 153-158 [Abstract] [Full Text]
Jacobson, J. M., Feinman, L., Liebes, L., Ostrow, N., Koslowski, V., Tobia, A., Cabana, B. E., Lee, D.-H., Spritzler, J., Prince, A. M. (2001). Pharmacokinetics, Safety, and Antiviral Effects of Hypericin, a Derivative of St. John's Wort Plant, in Patients with Chronic Hepatitis C Virus Infection. Antimicrob. Agents Chemother. 45: 517-524 [Abstract] [Full Text]
Harris, D. R., Gonin, R., Alter, H. J., Wright, E. C., Buskell, Z. J., Hollinger, F. B., Seeff, L. B., for the National Heart, Lung, and Blood Institute, (2001). The Relationship of Acute Transfusion-Associated Hepatitis to the Development of Cirrhosis in the Presence of Alcohol Abuse. ANN INTERN MED 134: 120-124 [Abstract] [Full Text]
Behrman, A. J., Thomas, D. L., Strathdee, S. A., Vlahov, D. (2000). Long-term Prognosis of Hepatitis C Virus Infection. JAMA 284: 2592-2592 [Full Text]
Wong, J. B., Koff, R. S. (2000). Watchful Waiting with Periodic Liver Biopsy versus Immediate Empirical Therapy for Histologically Mild Chronic Hepatitis C: A Cost-Effectiveness Analysis. ANN INTERN MED 133: 665-675 [Abstract] [Full Text]
Osella, A. R, Misciagna, G., Guerra, V. M, Chiloiro, M., Cuppone, R., Cavallini, A., Di Leo, A. (2000). Hepatitis C virus (HCV) infection and liver-related mortality: a population-based cohort study in southern Italy. Int J Epidemiol 29: 922-927 [Abstract] [Full Text]
Thomas, D. L., Astemborski, J., Rai, R. M., Anania, F. A., Schaeffer, M., Galai, N., Nolt, K., Nelson, K. E., Strathdee, S. A., Johnson, L., Laeyendecker, O., Boitnott, J., Wilson, L. E., Vlahov, D. (2000). The Natural History of Hepatitis C Virus Infection: Host, Viral, and Environmental Factors. JAMA 284: 450-456 [Abstract] [Full Text]
Degos, F, Christidis, C, Ganne-Carrie, N, Farmachidi, J-P, Degott, C, Guettier, C, Trinchet, J-C, Beaugrand, M, Chevret, S (2000). Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death. Gut 47: 131-136 [Abstract] [Full Text]
Shiratori, Y., Yoshida, H., Omata, M. (2000). Effects of Interferon Therapy on Inhibition of Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis C. Jpn J Clin Oncol 30: 213-214 [Full Text]
Farci, P., Shimoda, A., Coiana, A., Diaz, G., Peddis, G., Melpolder, J. C., Strazzera, A., Chien, D. Y., Munoz, S. J., Balestrieri, A., Purcell, R. H., Alter, H. J. (2000). The Outcome of Acute Hepatitis C Predicted by the Evolution of the Viral Quasispecies. Science 288: 339-344 [Abstract] [Full Text]
Gibb, D M, Neave, P E, Tookey, P A, Ramsay, M, Harris, H, Balogun, K, Goldberg, D, Mieli-Vergani, G, Kelly, D (2000). Active surveillance of hepatitis C infection in the UK and Ireland. Arch. Dis. Child. 82: 286-291 [Abstract] [Full Text]
Liang, T. J., Rehermann, B., Seeff, L. B., Hoofnagle, J. H. (2000). Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis C. ANN INTERN MED 132: 296-305 [Abstract] [Full Text]
Seeff, L. B., Miller, R. N., Rabkin, C. S., Buskell-Bales, Z., Straley-Eason, K. D., Smoak, B. L., Johnson, L. D., Lee, S. R., Kaplan, E. L. (2000). 45-Year Follow-up of Hepatitis C Virus Infection in Healthy Young Adults. ANN INTERN MED 132: 105-111 [Abstract] [Full Text]
Alter, M. J., Kruszon-Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., Kaslow, R. A., Margolis, H. S. (1999). The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994. NEJM 341: 556-562 [Abstract] [Full Text]
BjOro, K., Skaug, K., Haaland, T., FrOland, S.S. (1999). Long-term outcome of chronic hepatitis C virus infection in primary hypogammaglobulinaemia. QJM 92: 433-441 [Abstract] [Full Text]
Paul, I. M., Sanders, J., Ruggiero, F., Andrews, T., Ungar, D., Eyster, M. E. (1999). Chronic Hepatitis C Virus Infections in Leukemia Survivors: Prevalence, Viral Load, and Severity of Liver Disease. Blood 93: 3672-3677 [Abstract] [Full Text]
Kenny-Walsh, E., The Irish Hepatology Research Group, (1999). Clinical Outcomes after Hepatitis C Infection from Contaminated Anti-D Immune Globulin. NEJM 340: 1228-1233 [Abstract] [Full Text]
Datz, C, Cramp, M, Haas, T, Dietze, O, Nitschko, H, Froesner, G, Muss, N, Sandhofer, F, Vogel, W (1999). The natural course of hepatitis C virus infection 18�years after an epidemic outbreak of non-A, non-B hepatitis in a plasmapheresis centre. Gut 44: 563-567 [Abstract] [Full Text]
Wong, J. B., Bennett, W. G., Koff, R. S., Pauker, S. G. (1998). Pretreatment Evaluation of Chronic Hepatitis C: Risks, Benefits, and Costs. JAMA 280: 2088-2093 [Abstract] [Full Text]
McHutchison, J. G., Gordon, S. C., Schiff, E. R., Shiffman, M. L., Lee, W. M., Rustgi, V. K., Goodman, Z. D., Ling, M.-H., Cort, S., Albrecht, J. K., The Hepatitis Interventional Therapy Group, (1998). Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C. NEJM 339: 1485-1492 [Abstract] [Full Text]
Davis, G. L., Esteban-Mur, R., Rustgi, V., Hoefs, J., Gordon, S. C., Trepo, C., Shiffman, M. L., Zeuzem, S., Craxi, A., Ling, M.-H., Albrecht, J., The International Hepatitis Interventional Therapy, (1998). Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis C. NEJM 339: 1493-1499 [Abstract] [Full Text]
Liang, T. J. (1998). Combination Therapy for Hepatitis C Infection. NEJM 339: 1549-1550 [Full Text]
Locasciulli, A., Testa, M., Pontisso, P., Benvegnu, L., Fraschini, D., Corbetta, A., Noventa, F., Masera, G., Alberti, A. (1997). Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia. Blood 90: 4628-4633 [Abstract] [Full Text]
Rossi, G., Tucci, A., Cariani, E., Ravaggi, A., Rossini, A., Radaeli, E. (1997). Outbreak of Hepatitis C Virus Infection in Patients With Hematologic Disorders Treated With Intravenous Immunoglobulins: Different Prognosis According to the Immune Status. Blood 90: 1309-1314 [Abstract] [Full Text]
Cesaro, S., Petris, M. G., Rossetti, F., Cusinato, R., Pipan, C., Guido, M., Masiero, L., Botta, G. A., Meloni, G. A., Zanesco, L. (1997). Chronic Hepatitis C Virus Infection After Treatment for Pediatric Malignancy. Blood 90: 1315-1320 [Abstract] [Full Text]
Hoofnagle, J. H., Di Bisceglie, A. M. (1997). The Treatment of Chronic Viral Hepatitis. NEJM 336: 347-356 [Full Text]
Rogers, S. (1996). Hepatitis C: Watch for the Many or Treat for the Few?. JAMA 276: 280-280 [Abstract]
Sorrell, M. F. (1996). Hepatitis C: Watch for the Many or Treat for the Few?-Reply. JAMA 276: 280-281 [Abstract]
Schreiber, G. B., Busch, M. P., Kleinman, S. H., Korelitz, J. J., The Retrovirus Epidemiology Donor Study, (1996). The Risk of Transfusion-Transmitted Viral Infections. NEJM 334: 1685-1690 [Abstract] [Full Text]
Conry-Cantilena, C., VanRaden, M., Gibble, J., Melpolder, J., Shakil, A. O., Viladomiu, L., Cheung, L., DiBisceglie, A., Hoofnagle, J., Shih, J. W., Kaslow, R., Ness, P., Alter, H. J. (1996). Routes of Infection, Viremia, and Liver Disease in Blood Donors Found to Have Hepatitis C Virus Infection. NEJM 334: 1691-1696 [Abstract] [Full Text]
Alter, H. J. (1996). The Cloning and Clinical Implications of HGV and HGBV-C. NEJM 334: 1536-1537 [Full Text]
Sorrell, M. F. (1996). A 47-Year-Old Man With Asymptomatic Hepatitis C Infection. JAMA 275: 1023-1029 [Abstract]
Gane, E. J., Portmann, B. C., Naoumov, N. V., Smith, H. M., Underhill, J. A., Donaldson, P. T., Maertens, G., Williams, R. (1996). Long-Term Outcome of Hepatitis C Infection after Liver Transplantation. NEJM 334: 815-821 [Abstract] [Full Text]
Colquhoun, S. D. (1996). Hepatitis C: A Clinical Update. Arch Surg 131: 18-23 [Abstract]
Neumayr, G., Vogel, W., Tong, M. J., El-Farra, N. S. (1995). Outcomes after Transfusion-Associated Hepatitis C. NEJM 333: 1224-1224 [Full Text]
Tong, M. J., El-Farra, N. S., Reikes, A. R., Co, R. L. (1995). Clinical Outcomes after Transfusion-Associated Hepatitis C. NEJM 332: 1463-1466 [Abstract] [Full Text]
Terrault, N., Wright, T. (1995). Interferon and Hepatitis C. NEJM 332: 1509-1511 [Full Text]
Etchason, J., Petz, L., Keeler, E., Calhoun, L., Kleinman, S., Snider, C., Fink, A., Brook, R. (1995). The Cost Effectiveness of Preoperative Autologous Blood Donations. NEJM 332: 719-724 [Abstract] [Full Text]
Bjoro, K., Froland, S. S., Yun, Z., Samdal, H. H., Haaland, T. (1994). Hepatitis C Infection in Patients with Primary Hypogammaglobulinemia after Treatment with Contaminated Immune Globulin. NEJM 331: 1607-1611 [Abstract] [Full Text]
Petz, L. D., Kleinman, S. (1993). HIV-Infected Patients Participating in Autologous Blood Programs. JAMA 270: 2181-2181 [Abstract]
Eddy, D. M. (1993). Three Battles to Watch in the 1990s. JAMA 270: 520-526 [Abstract]

Comments and questions? Please contact us.